The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127039611 12703961 1 I 20160823 20160831 20160831 PER US-ELI_LILLY_AND_COMPANY-US201608011683 ELI LILLY AND CO 0.00 F Y 0.00000 20160831 CN UA US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127039611 12703961 1 PS GEMZAR GEMCITABINE HYDROCHLORIDE 1 Intravenous (not otherwise specified) 1870 MG, CYCLICAL 20509 1870 MG INJECTION
127039611 12703961 2 SS ABRAXANE PACLITAXEL 1 Intravenous (not otherwise specified) 185 MG, CYCLICAL 15F1239 0 185 MG
127039611 12703961 3 C ALBUTEROL /00139501/ ALBUTEROL 1 Oral U 0
127039611 12703961 4 C VOLTAREN DICLOFENAC SODIUM 1 2 G, QID U 0 2 G QID
127039611 12703961 5 C DULOXETINE. DULOXETINE 1 Unknown 60 MG, QD U 0 60 MG QD
127039611 12703961 6 C VITAMIN D /00107901/ ERGOCALCIFEROL 1 Unknown 50000 U, UNKNOWN U 0 50000 IU
127039611 12703961 7 C ADVAIR HFA FLUTICASONE PROPIONATESALMETEROL XINAFOATE 1 Unknown 1 DF, BID U 0 1 DF BID
127039611 12703961 8 C GUAIFENESIN. GUAIFENESIN 1 Unknown 600 MG, BID U 0 600 MG BID
127039611 12703961 9 C LORAZEPAM. LORAZEPAM 1 Oral 0.5 MG, QID U 0 .5 MG QID
127039611 12703961 10 C PLAQUENIL /00072602/ HYDROXYCHLOROQUINE DIPHOSPHATE 1 Unknown 200 MG, BID U 0 200 MG BID
127039611 12703961 11 C MONTELUKAST MONTELUKAST SODIUM 1 Unknown 10 MG, QD U 0 10 MG QD
127039611 12703961 12 C ZOFRAN ONDANSETRON HYDROCHLORIDE 1 Unknown 8 MG, TID U 0 8 MG TID
127039611 12703961 13 C PERCOCET /00446701/ ACETAMINOPHENOXYCODONE HYDROCHLORIDEOXYCODONE TEREPHTHALATE 1 Oral 1 UNK, UNK U 0
127039611 12703961 14 C PREDNISONE. PREDNISONE 1 Oral UNK, QD U 0 QD
127039611 12703961 15 C LYRICA PREGABALIN 1 Oral 200 MG, BID U 0 200 MG BID
127039611 12703961 16 SS SPIRIVA TIOTROPIUM BROMIDE MONOHYDRATE 1 Unknown 1 DF, QD U 0 1 DF QD
127039611 12703961 17 C LEVOFLOXACIN. LEVOFLOXACIN 1 Oral 500 MG, QD U 0 500 MG QD
127039611 12703961 18 C OXYGEN. OXYGEN 1 Unknown 2 L, UNKNOWN U 0 2 L

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127039611 12703961 1 Lung neoplasm malignant
127039611 12703961 2 Lung neoplasm malignant
127039611 12703961 4 Pain
127039611 12703961 13 Pain

Outcome of event

Event ID CASEID OUTC COD
127039611 12703961 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
127039611 12703961 Platelet count decreased
127039611 12703961 Pneumonia bacterial
127039611 12703961 Upper respiratory tract infection
127039611 12703961 Urine analysis abnormal

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
127039611 12703961 1 20160524 20160621 0
127039611 12703961 2 20160524 20160621 0